Table:
begin	end	state
1	20	cytoplasmic
21	43	transmembrane
44	49	non-cytoplasmic
50	73	transmembrane
74	84	cytoplasmic
85	103	transmembrane
104	108	non-cytoplasmic
109	130	transmembrane
131	149	cytoplasmic
150	173	transmembrane
174	184	non-cytoplasmic
185	205	transmembrane
206	239	cytoplasmic
240	259	transmembrane
260	279	non-cytoplasmic
280	300	transmembrane
301	306	cytoplasmic
307	326	transmembrane
327	409	non-cytoplasmic
410	434	transmembrane
435	449	cytoplasmic
450	472	transmembrane
473	478	non-cytoplasmic
479	497	transmembrane
498	507	cytoplasmic

Input:
>CA265_RS19920
MSDTLPRNNIFKVIGASSLGTLIEWYDFYIFGSLAVIIGHQLFPEDAGASALINTLAIFA
AGFIVRPFGALVFGRLGDLIGRKYTFLLTLVLMGGSTFFIGLIPSYKSIGYAAPILVLIL
RLIQGLALGGEYGGAATYVAEHAPKNKRGFFTSWIQTTATLGLFLSLGIIVITKNILGAE
TFGDWGWRIPFLLSIVLVVVSIYIRMKMHESPMFSKLKAEGNVSKNPLKESFNNKANFKM
VLLALFGATMGQGVIWYTGQFYAQSFLENTCKLDFNDSRYILLWGIAFATPFFVIFGAWS
DKVGRKWIMLSGMLLGILFYRPIYQIFLDDTDYTKIEQTDILSARPAPVTSVLIANSTDS
LRTVSTKVMLKNGASFNKVQTDTVSATKGILLGKEVVKDKILPTPVFWKFVGLIFFQILL
VTMVYGPIAAFLVELFPTKIRYTSMSLPYHIGNGVFGGLVPFIATLIASFSGSTPLSGLW
YPIGIAALSLVIGAIYLSNKRDENIND

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server